Formulations for treating acid reflux comprising sodium alginate
AssigneePharagen LLC
InventorJoseph Ryan Smolarz
Life of this patent
Estimating the term…
Abstract
The disclosure provides for pharmaceutical compositions comprising an alginate salt, such as sodium alginate. The disclosure further provides for processes and methods for making pharmaceutical compositions. In yet a further aspect, the disclosure provides for methods of utilizing a pharmaceutical composition for treatment of acid reflux diseases. In another aspect, the disclosure provides for formulations suitable for oral use in dosage forms of capsules and dry powders.
Claims21
A method of treating acid reflux disease in an individual in need thereof, comprising administering to an individual in need thereof a pharmaceutical composition formulated as a powder consisting of:
- (i) one or more alginate salts, present in an amount from about 30% to 78% wt of the pharmaceutical composition,
- (ii) sodium bicarbonate, present in an amount from about 1% to 10% wt of the pharmaceutical composition,
- (iii) calcium carbonate, present in an amount from about 1% to 10% wt of the pharmaceutical composition,
- (iv) citric acid, present in an amount from about 21% to 30% wt of the pharmaceutical composition,
- (v) optionally one or more natural or artificial sweetener or flavorants;
- and
- dissolving the powder form in liquid prior to administration to individual and wherein the composition forms alginate raft prior to administering to an individual.
Dependencies are inferred from the claim text.